SCHEMBL3733796

SCHEMBL3733796

COc1ccc2c(c1)C(=O)c1c-2c(O)nc2ccccc12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GUSB P08236 1/20 0.52
NTRK1 P04629 3/20 0.50
KDM4E B2RXH2 2/20 0.49
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
POLB P06746 1/20 0.49
PTPN1 P18031 1/20 0.45
RXRA P19793 1/20 0.45
GRM2 Q14416 1/20 0.45
ACHE P22303 2/20 0.44
SMN1; SMN2 Q16637 1/20 0.43
ELANE P08246 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
CCNB2 O95067 1/20 0.43
CDK1 P06493 1/20 0.43
CCNB1 P14635 1/20 0.43
GSK3A P49840 1/20 0.43
GSK3B P49841 1/20 0.43
CDK5 Q00535 1/20 0.43
CDK5R1 Q15078 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3736581 0.85 NTRK1 (0.51) GUSBNTRK1KDM4EMEN1KMT2A
SCHEMBL3738459 0.82 MEN1 (0.51) GUSBKDM4EMEN1KMT2APOLB
SCHEMBL3738460 0.82 MEN1 (0.51) GUSBKDM4EMEN1KMT2APOLB
SCHEMBL7822017 0.82 NTRK1 (0.51) GUSBNTRK1KDM4EMEN1KMT2A
SCHEMBL16895277 0.80 APAF1 (0.49) GUSBKDM4EMEN1KMT2AGRM2
SCHEMBL14796305 0.79 NTRK1 (0.45) GUSBNTRK1KDM4EMEN1KMT2A
SCHEMBL14796306 0.78 TOP1 (0.46) GUSBNTRK1KDM4EMEN1KMT2A
SCHEMBL8810834 0.77 CYP1A2 (0.53) NTRK1MEN1KMT2APOLBSMN1; SMN2
SCHEMBL7811355 0.77 NTRK1 (0.50) GUSBNTRK1KDM4EMEN1KMT2A
SCHEMBL3741119 0.76 TOP1 (0.56) GUSBNTRK1POLBPTPN1RXRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7829567-B2 Imino-indeno[1,2-c] quinoline derivatives, their preparation processes, and pharmaceutical compositions comprising the same KAOHSIUNG MEDICAL UNIVERSITY (TW) 2010-11-09 US disclosed
US-20090111987-A1 Imino-Indeno[1,2-c] quinoline derivatives, their preparation processes, and pharmaceutical compositions comprising the same KAOHSIUNG MEDICAL UNIVERSITY (TW) 2009-04-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090111987-A1 Imino-Indeno[1,2-c] quinoline derivatives, their preparation processes, and pharmaceutical compositions comprising the same IMPA1, IMPDH1, IPO5 GUSB 4154/4885NTRK1 4732/4885KDM4E 1726/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.